BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 30, 2008
View Archived Issues
HSPA12B, a novel target for antiangiogenesis therapy
Read More
Novel monoclonal antibodies show low tendency for bleeding in models of arterial thrombosis
Read More
Titan presents positive phase III results for Probuphine in opioid addiction
Read More
FDA grants orphan drug designation to Polyphenon's Polyphenon E for CLL
Read More
Allergan to initiate phase I clinical development of retargeted endopeptidase drug candidate
Read More
CHMP recommends refusal of Santhera's MAA for Sovrima in Friedreich's ataxia
Read More
FDA issues not approvable letter in response to Vanda's NDA for iloperidone in schizophrenia
Read More
Anticoagulant Xarelto recommended for approval in E.U.; NDA submitted in U.S.
Read More
Chinese SFDA approves Nexavar for HCC
Read More
No improvement with BioBypass gene therapy in patients with refractory ischemia
Read More
A Ginkgo biloba extract improves cognitive and neuropsychiatric symptoms in AD and vascular dementia
Read More
Clinical results with bapineuzumab immunotherapy in mild to moderate AD reported at ICAD
Read More
GPC Biotech reports withdrawal of MAA for satraplatin in prostate cancer
Read More
FDA issues not approvable letter to Eisai for sedative-hypnotic agent fospropofol disodium
Read More
SuperArray Bioscience changes name to SABiosciences
Read More
Merck & Co places development hold on HIV protease inhibitor PPL-100
Read More
CHMP recommends marketing authorization for GSK's prepandemic influenza vaccine
Read More
Sanofi pasteur agrees terms of cash offer for share capital of Acambis
Read More
Arpida submits MAA to the EMEA for iclaprim in cSSTI
Read More
Roche submits application to EMEA to extend label for Avastin in breast cancer
Read More
MediGene's Oracea receives marketing authorization in Europe
Read More
Nuvelo commences phase I NU-206 trial in healthy volunteers
Read More
European Commission approves Schering-Plough's Bridion
Read More
Novel antidiabetic agents claimed in recent patents
Read More
Advances in development of agents for neurological disorders documented in recent patents
Read More
FDA issues not approvable letter to UCB for Vimpat in diabetic neuropathic pain
Read More
Novel Rho kinase inhibitors developed at sanofi-aventis
Read More